How bad is CBD oil mislabelling in the UK?

A study by a leading UK cannabis-advocacy group suggests that CBD oil mislabeling effects over 60% of products available in the UK. The UK-based research was conducted following a US study that found inaccurate labelling of almost 70% of cannabidiol (CBD) products brought online.… Legal

How important is heavy metals testing for CBD?

Research

Written by Analytical Chemist
18th September 2019

Improve CBD Product with Terpene Analysis

How terpenes can improve your CBD product

Research

Written by Analytical Chemist
18th September 2019

CBD UK Law: What you need to know

Legal

Written by Analytical Chemist
21st January 2020

Choosing a concentrate for your CBD product

Research

Written by Analytical Chemist
4th March 2020

The Importance of Testing CBD Products

Research

Written by Analytical Chemist
5th March 2021

CBD Extraction Processes Worth Knowing

Research

Written by Analytical Chemist
5th March 2021

Analytical Request Form

Submit your product for testing using the analytical request form below

1 Customer Info

2 Test Info

3 Authorisation

Name
First Last
Company name to appear on certificate*
VAT No. (only applicable to EU companies)
Address*
Street Address Address Line 2 City County Post code Country
Customer email*
Customer phone*

Submit products for testing
Sample description Actions
Edit

Delete
There are no Entries.
Maximum number of entries reached.

Special instructions
Authorisation*
Date*
Date Format: DD slash MM slash YYYY
While LOQs (limit of quantification) per analyte are included on the report, uncertainties will be available on request.

By submitting products for Testing with PhytoVista Laboratories, the customers agree that their samples fit the below criteria:
the controlled drug in any component part is packaged in such a form, or in combination with other active or inert substances in such a manner, that it cannot be recovered by readily applicable means or in a yield which constitutes a risk to health;*
- the controlled drug in any component part is packaged in such a form, or in combination with other active or inert substances in such a manner, that it cannot be recovered by readily applicable means or in a yield which constitutes a risk to health;
no one component part of the product or preparation contains more than one milligram of the controlled drug or one microgram in the case of lysergide or any other N-alkyl derivative of lysergamide*
- no one component part of the product or preparation contains more than one milligram of the controlled drug or one microgram in the case of lysergide or any other N-alkyl derivative of lysergamide
Opt in
- I would like to sign up to receive email updates from PhytoVista Laboratories

I acknowledge that I have read and understood the Terms & Conditions of PhytoVista Laboratories

Sample description	Actions
	Edit Delete
There are no Entries.